Safety and efficacy of pertuzumab plus trastuzumab and taxanes in patients with HER2+ metastatic breast cancer:A multicenter, retrospective-prospective, observational study

Trial Profile

Safety and efficacy of pertuzumab plus trastuzumab and taxanes in patients with HER2+ metastatic breast cancer:A multicenter, retrospective-prospective, observational study

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Jan 2018

At a glance

  • Drugs Pertuzumab (Primary) ; Trastuzumab (Primary)
  • Indications Advanced breast cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms G.O.N.O. SUPER
  • Most Recent Events

    • 12 Jan 2018 New trial record
    • 09 Dec 2017 Preliminary (n=217) presented at the 40th Annual San Antonio Breast Cancer Symposium
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top